potraviny/epilobii-herba/produkty
E. angustifolium; E. parviflorum and other small flowered Epilobium species
- Treatment of benign prostatic hyperplasia
Herbal tea for oral use
- 1 heaped teaspoon per 250 ml of boiling water,
- 2 cups per day
- 1 cup in the morning on an empty stomach, 1 cup in the evening half an hour before a meal)
Treben (1978, 1980, 1982, 1986), , Hänsel et al. (1993), Wichtl & Tadros (1982), Wichtl (1984), Schilcher (1982, 1984), Lachinger (2004), Gerlach (2007), Granica et al. (2014)
Hungary Herbal tea
- 1 tea bag containing
- 0.175 g Epilobii herba,
- 0.175 g Equiseti herba,
- 0.175 g Matricariae flos,
- 0.175 g Urticae folium
Indication:
- Relief of urinary symptoms of benign prostatic hypertrophy
Posology:
- 2 tea bags 3 times daily
- On the market since: 11/04/2005 [1]
Herbal tea for oral use in Benign prostatic hyperplasia
- 1.5-2.0 g of the comminuted herbal substance in 250 ml of water as an herbal infusion 2 times daily.
- Since 1982 ) Wichtl & Tadros (1982), Wichtl (1984), Schilcher (1982, 1984)
Herbal tea
- 100 g herbal tea containing
- 30 g Epilobii angustifolii herba,
- 30 g Urticae radix,
- 20 g Uvae ursi folium,
- 20 g Herniariae herba.
Indication:
- Inflammation of the bladder,
- Irritable bladder
- Prevention of prostate related disorders
Posology:
- 1 heaped teaspoon/150 ml of boiling water
- 2 times daily
- If necessary several times daily.
Registation
- Austria:
- Three combination products (herbal tea) containing Epilobium angustifolium L.
- Simplified procedure according to special national provisions (§11a Austrian Medicines Act)
Herbal tea
- 100 g herbal tea containing
- 20 g Orthosiphonis folium,
- 20 g Uvae ursi folium,
- 20 g Epilobii angustifolii herba,
- 20 g Herniariae herba,
- 10 g Solidaginis herba,
- 10 g Ericae herba,
Indication:
- Flushing of the urinary tract
- Adjuvant treatment of symptoms related to inflammation of the bladder and irritative bladder.
Posology:
- 2 teaspoons/150 ml of boiling water, 3-4 times daily
- On the market since 1993
Registation
- Austria:
- Three combination products (herbal tea) containing Epilobium angustifolium L.
- Simplified procedure according to special national provisions (§11a Austrian Medicines Act)
Posology
According to Treben (1980)
- 1 heaped teaspoon per 250 ml of boiling water
- One cup of tea should be taken in the morning on an empty stomach
- 1 cup in the evening half an hour before a meal
According to Wichtl (1984, 2009)
- Single dose is 1.5 – 2.0 g
- Consequently the daily dose is 3-4 g
Czech Pharmaceutical Codex (Český farmaceutický kodex 1993)
- Therapeutic dose is a single oral dose as an infusion using 2.0 g of the herbal substance
E. parviflorum, Epilobium montanum, E. collinum, E. roseum
- Diuretic,
- Adstringent
- Herbal tea for oral use
- Single dose: 2.0 of the herbal substance
- Czech Pharmaceutical Codex (1993) [1]
Epilobin Planta herbal tea
- 1 tea bag containing
- 750 mg Epilobii herba,
- 375 mg Bucco folium,
- 225 mg Solidaginis virgaureae herba,
- 150 mg Calendulae flos cum calyce
Indication:
- Symptomatic treatment of mild micturition disorders related to benign prostatic hyperplasia
Registration
- Czech Republic
Posology:
- 1 tea bag/300 ml of boiling water,
- 2-3 times daily
- On the market since: 1999
- Registration was granted in the old legislative frame in 1999
- Switched to current TUR within the transition period in 2011 [1]
Oral drops
- 1 ml liquid extract containing
- 80.00 mg Epilobii herba
- 80.00 mg Urticae folium
- 53.40 mg Urticae radix
- 40.00 mg Solidaginis herba
- 13.40 mg Foeniculi dulcis fructus
- DER 1:5,
- Extraction solvent: ethanol
Indication:
- Relief of urinary symptoms of benign prostatic hypertrophy and inflammation at the initial stage of disease
Posology:
- 30 drops 3 times daily
- On the market since: 25/07/2002 [1]
Products containing the single active substance Epilobium parviflorum, herba
- On the market in CZ and HU
- Combination products were or are still on the market in AT, CZ, and HU
- Treatment of symptoms of benign prostatic hyperplasia is well documented
- Data are too scarce concerning the use in bladder and kidney disorders
